|
TCOF1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.656400E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.117170E-01 |
| Normal-vs-Stage2 |
4.502200E-02 |
| Normal-vs-Stage3 |
3.243800E-01 |
| Normal-vs-Stage4 |
1.274260E-02 |
| Stage1-vs-Stage2 |
2.271400E-01 |
| Stage1-vs-Stage3 |
6.448000E-01 |
| Stage1-vs-Stage4 |
7.239500E-02 |
| Stage2-vs-Stage3 |
1.546590E-01 |
| Stage2-vs-Stage4 |
6.939600E-01 |
| Stage3-vs-Stage4 |
4.992100E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.551600E-02 |
| Normal-vs-AfricanAmerican |
2.189000E-01 |
| Normal-vs-Asian |
3.973900E-02 |
| Caucasian-vs-AfricanAmerican |
8.727800E-01 |
| Caucasian-vs-Asian |
6.325800E-01 |
| AfricanAmerican-vs-Asian |
6.206200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.865800E-01 |
| Normal-vs-Female |
3.102300E-02 |
| Male-vs-Female |
3.227800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.014240E-01 |
| Normal-vs-Age(41-60Yrs) |
1.434390E-01 |
| Normal-vs-Age(61-80Yrs) |
6.731600E-02 |
| Normal-vs-Age(81-100Yrs) |
1.509000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.797400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.288600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.766000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.356000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.008600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.353600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.809200E-01 |
| Classical-VS-Follicular |
2.57980000029079E-07 |
| Classical-VS-Other |
1.197800E-01 |
| Classical-VS-Normal |
1.295900E-03 |
| Tall-VS-Follicular |
2.216000E-02 |
| Tall-VS-Other |
4.130200E-01 |
| Tall-VS-Normal |
1.494010E-01 |
| Follicular-VS-Other |
9.071800E-01 |
| Follicular-VS-Normal |
2.404000E-01 |
| Other-VS-Normal |
7.594400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.555570E-01 |
| Normal-vs-N1 |
1.074800E-01 |
| N0-vs-N1 |
4.130800E-01 |
|
|
